The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_001754.5(RUNX1):c.447A>C (p.Ala149=)

CA512318720

1142684 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: fdc5cdaa-936b-42dd-9c1c-ffb4c241a00a
Approved on: 2022-07-06
Published on: 2022-07-06

HGVS expressions

NM_001754.5:c.447A>C
NM_001754.5(RUNX1):c.447A>C (p.Ala149=)
NC_000021.9:g.34880618T>G
CM000683.2:g.34880618T>G
NC_000021.8:g.36252915T>G
CM000683.1:g.36252915T>G
NC_000021.7:g.35174785T>G
NG_011402.2:g.1109094A>C
ENST00000675419.1:c.447A>C
ENST00000300305.7:c.447A>C
ENST00000344691.8:c.366A>C
ENST00000358356.9:c.366A>C
ENST00000399237.6:c.411A>C
ENST00000399240.5:c.366A>C
ENST00000437180.5:c.447A>C
ENST00000455571.5:c.408A>C
ENST00000482318.5:c.*37A>C
NM_001001890.2:c.366A>C
NM_001122607.1:c.366A>C
NM_001754.4:c.447A>C
NM_001001890.3:c.366A>C
NM_001122607.2:c.366A>C

Uncertain Significance

Met criteria codes 2
PM2_Supporting BP4
Not Met criteria codes 24
BS2 BS4 BS3 BS1 PVS1 BP5 BP7 BP2 BP3 BP1 PS2 PS4 PS3 PS1 PP4 PP1 PP3 PP2 BA1 PM3 PM1 PM4 PM5 PM6

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.447A>C (p.Ala149=) is a synonymous variant. No REVEL score because a synonymous variant and SpliceAI is ≤0.20 (BP4). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, this variant meets the criteria to be classified as a variant of Uncertain significance - insufficient evidence. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4 and PM2_supporting.
Met criteria codes
PM2_Supporting
This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2)
BP4
No REVEL score. SpliceAI doesn't predict any significant splicing impact (Δ scores ≤ 0.20).
Not Met criteria codes
BS2
This rule is not applicable for MM-VCEP
BS4
No case studies found
BS3
No evidence found
BS1
Meets PM2_supporting
PVS1
N/A
BP5
This rule is not applicable for MM-VCEP
BP7
The c.447A>C (p.Ala149=) variant is a synonymous (silent) variant. SpliceAI doesn't predict any significant splicing impact (Δ scores ≤ 0.20). Evolutionary algorithms predict site is conserved - PhyloP score 4.9
BP2
No homozygotes observed in gnomAD population (v2 and v3)
BP3
This rule is not applicable for MM-VCEP
BP1
This rule is not applicable for MM-VCEP
PS2
No case studies found
PS4
No case studies found
PS3
No evidence found
PS1
N/A
PP4
N/A
PP1
No case studies found
PP3
SpliceAI doesn't predict any significant splicing impact (Δ scores ≤ 0.20).
PP2
This rule is not applicable for MM-VCEP
BA1
Meets PM2_supporting
PM3
This rule is not applicable for MM-VCEP
PM1
N/A
PM4
N/A
PM5
N/A
PM6
No case studies found
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.